In vivo measurement of the hypoxia marker EF5 in Shionogi tumours using ¹⁹F magnetic resonance spectroscopy

References

• Aboagye E O, Lewis A D, Johnson A, Workman P, Tracy M, Huxham I M. The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: Reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis. British Journal of Cancer 1995; 72: 312–318
   PubMed Web of Science ®Google Scholar
• Aboagye E O, Maxwell R J, Kelson A B, Tracy M, Lewis A D, Graham M A, Horsman M R, Griffiths J R, Workman P. Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia. Cancer Research 1997; 57: 3314–3318
   PubMed Web of Science ®Google Scholar
• Chapman J D, Franko A J, Sharplin J. A marker for hypoxic cells in tumours with potential clinical applicability. British Journal of Cancer 1981; 43: 546–550
   PubMed Web of Science ®Google Scholar
• Chapman J D, Baer K, Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Research 1983; 43: 1523–1528
   PubMed Web of Science ®Google Scholar
• Clark L C, Jr, Wolf R, Granger D, Taylor Z. Continuous recording of blood oxygen tensions by polarography. Journal of Applied Physiology 1953; 6: 189–193
   PubMed Web of Science ®Google Scholar
• Gray L H, Conger A D, Ebert M, Hornsey, Scott O C. Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. British Journal of Radiology 1953; 26: 638–648
   PubMed Web of Science ®Google Scholar
• Hodgkiss R J. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia. Anti-Cancer Drug Design 1998; 13: 687–702
   PubMedGoogle Scholar
• Jeffrey F M, Storey C J, Nunnally R L, Malloy C R. Effect of ischemia on NMR detection of phosphorylated metabolites in the intact rat heart. Biochemistry 1989; 28: 5323–5326
   PubMedGoogle Scholar
• Kolstad P. Intercapillary distance, oxygen tension and local recurrence in cervix cancer. Scandinavian Journal of Clinical & Laboratory Investigation 1968; 106: 145–157
   Google Scholar
• Kwock L, Gill M, McMurry H L, Beckman W, Raleigh J A, Joseph A P. Evaluation of a fluorinated 2-nitroimidazole binding to hypoxic cells in tumor-bearing rats by 19F magnetic resonance spectroscopy and immunohistochemistry. Radiation Research 1992; 129: 71–78
   PubMedGoogle Scholar
• Laughlin K M, Evans S M, Jenkins W T, Tracy M, Chan C Y, Lord E M, Koch C J. Biodistribution of the nitroimidazole EF5 (2-[2-nitro-1H-imidazol-1-yl]-N-(2,2,3,3,3-pentafluoropropyl) acetamide) in mice bearing subcutaneous EMT6 tumors. Journal of Pharmacology and Experimental Therapeutics 1996; 277: 1049–1057
   PubMed Web of Science ®Google Scholar
• Lord E M, Harwell L, Koch C J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Research 1993; 53: 5721–5726
   PubMedGoogle Scholar
• Milross C G, Peters L J, Hunter N R, Mason K A, Tucker S L, Milas L. Polarographic pO2 measurement in mice: effect of tumor type, site of implantation, and anaesthesia. Radiation Oncology Investigations 1996; 4: 108–114
   Google Scholar
• Minesita T, Yamaguchi K. An androgen-dependent mouse mammary tumor. Cancer Research 1965; 25: 1168–1175
   PubMedGoogle Scholar
• Mottram J C. Factor of importance in the radiosensitivity of tumours. British Journal of Radiology 1936; 9: 606–614
   Google Scholar
• Procissi D, Claus F, Burgman P, Koziorowski J, Chapman J D, Thakur S B, Matei C, Ling C C, Koutcher J A. In vivo19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors. Clinical Cancer Research 2007; 13: 3738–3747
   PubMedGoogle Scholar
• Raleigh J A, Franko A J, Treiber E O, Lunt J A, Allen P S. Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumors in Balb/C mice: Detection by F-19 nuclear magnetic resonance at 2.35 T. International Journal of Radiatian Oncology, Biology and Physics 1986; 12: 1243–1245
   PubMedGoogle Scholar
• Raleigh J A, Koch C J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochemical Pharmacology 1990; 40: 2457–2464
   PubMedGoogle Scholar
• Rasey J S, Grunbaum Z, Magee S, Nelson N J, Olive P L, Durand R E, Krohn K A. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. Radiation Research 1987; 111: 292–304
   PubMed Web of Science ®Google Scholar
• Robinson S P, Griffiths J R. Current issues in the utility of 19F nuclear magnetic resonance methodologies for the assessment of tumour hypoxia. Philosophical Transactions of the Royal Society of London, Series B 2004; 359: 987–996
   PubMed Web of Science ®Google Scholar
• Salmon H W, Siemann D W. Utility of 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors. Radiotherapy and Oncology 2004; 73: 359–366
   PubMedGoogle Scholar
• Seddon B M, Maxwell R J, Honess D J, Grimshaw R, Raynaud F, Tozer G M, Workman P. Validation of the fluorinated 2-nitroimidazole SR-4554 as a noninvasive hypoxia marker detected by magnetic resonance spectroscopy. Clinical Cancer Research 2002; 8: 2323–2335
   PubMedGoogle Scholar
• Silver A RJ, McNeil S S, O'Neill P, Jenkins T C, Ahmed I. Induction of DNA strand breaks by reduced nitroimidazoles: Implications for DNA base damage. Biochemical Pharmacology 1986; 35: 3923–3928
   PubMed Web of Science ®Google Scholar
• Skov K, Adomat H, Bowden M, Dragowska W, Gleave M, Koch C J, Woo J, Yapp D T. Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages. Radiation Research 2004; 162: 547–553
   PubMed Web of Science ®Google Scholar
• Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. Journal of Magnetic Resonance 1997; 129: 35–43
   PubMed Web of Science ®Google Scholar
• Varghese A J, Whitmore G F. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. Cancer Research 1980; 40: 2165–2169
   PubMed Web of Science ®Google Scholar
• Varghese A J. Glutathione conjugates of misonidazole. Biochemical and Biophysical Research Communications 1983; 112: 1013–1020
   PubMed Web of Science ®Google Scholar